BIO-OMEPRAZOLE 20 MG
OMEPRAZOLE (OMEPRAZOLE MAGNESIUM) : 20 MG · DIN 02449927 · BIOMED PHARMA
Health Canada status: MARKETED
What is BIO-OMEPRAZOLE?
BIO-OMEPRAZOLE 20 MG contains OMEPRAZOLE (OMEPRAZOLE MAGNESIUM) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02449927, held by BIOMED PHARMA, supplied as TABLET (DELAYED-RELEASE) for ORAL administration. Health Canada currently lists it as marketed, status dated 07-Sep-2016. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is BIO-OMEPRAZOLE used for?
BIO-OMEPRAZOLE are indicated in the treatment of conditions where a reduction of gastric acid secretion is required, such as: duodenal ulcer; gastric ulcer; NSAID-associated gastric and duodenal ulcers; reflux esophagitis; symptomatic gastroesophageal reflux disease (GERD) i.e. , heartburn and regurgitation; dyspepsia; Zollinger-Ellison syndrome (pathological hypersecretory condition); eradication of Helicobacter pylori (H. pylori). BIO-OMEPRAZOLE in combination with clarithromycin and either amoxicillin or metronidazole, are indicated for the treatment of patients with peptic ulcer disease associated with Helicobacter pylori infection.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02449927 |
|---|---|
| Brand name | BIO-OMEPRAZOLE |
| Generic / active ingredient | OMEPRAZOLE (OMEPRAZOLE MAGNESIUM) : 20 MG |
| Manufacturer | BIOMED PHARMA |
| Strength | 20 MG |
| Dosage form | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A02BC01 OMEPRAZOLE |
| AHFS class | 56:28.36 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 07-Sep-2016 |
| Original market date | 2016-09-07 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code A02BC01 OMEPRAZOLE. 12 of 57 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-OMEPRAZOLE | 20 MG | TABLET (DELAYED-RELEASE) | ACCORD HEALTHCARE INC | MARKETED | DIN 02416549 |
| APO-OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02245058 |
| HEARTBURN CONTROL | 20 MG | CAPSULE (DELAYED RELEASE) | APOTEX INC | MARKETED | DIN 02435683 |
| JAMP-OMEPRAZOLE DR | 20 MG | TABLET (DELAYED-RELEASE) | JAMP PHARMA CORPORATION | MARKETED | DIN 02420198 |
| LOSEC | 20 MG | CAPSULE (DELAYED RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 00846503 |
| LOSEC MUPS | 20 MG | TABLET (DELAYED-RELEASE) | CHEPLAPHARM ARZNEIMITTEL GMBH | MARKETED | DIN 02242462 |
| OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | PRO DOC LIMITEE | MARKETED | DIN 02339927 |
| OMEPRAZOLE | 20 MG | CAPSULE (DELAYED RELEASE) | SANIS HEALTH INC | MARKETED | DIN 02348691 |
| OMEPRAZOLE-20 | 20 MG | CAPSULE (DELAYED RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02411857 |
| TEVA-OMEPRAZOLE | 10 MG | TABLET (DELAYED-RELEASE) | TEVA CANADA LIMITED | MARKETED | DIN 02295407 |
Who else supplies OMEPRAZOLE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OMEPRAZOLE appears in 1096 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.